Cupid Limited Strengthens IVD Test Kits Business with Certification Pipeline, Capacity Expansion, & Global Market Expansion

Cupid Limited is rapidly scaling its In-Vitro Diagnostic (IVD) test kits business, driven by strong domestic demand, a growing international footprint, and a clear expansion strategy. The company has a diverse product portfolio of 15 IVD rapid test kits, with 3 new ones under development. Regulatory certifications are in progress, including CE Certification for 4 key products and WHO Prequalification for the Malaria Pf Pv Ag Test Kit. The company is eligible for all Central and State Government tenders after completing 3 years of production at the Maharashtra facility. It is also supplying 120+ ESIC hospitals via the Government e-Marketplace with regular order flows. The company is planning to increase its capacity to 4 lakh kits per day by the end of 2026 through phased automation. Country registrations have been completed, and business has been initiated in several countries. The IVD segment is expected to become a key growth engine for the company.